Doxepin Should NOT Be Used to Treat Passive Thoughts of Self-Harm
Doxepin is not indicated for suicidal ideation and carries a black box warning that antidepressants, including doxepin, may increase the risk of suicidal thinking and behavior, particularly during early treatment phases. 1
Critical Safety Concerns
The FDA label explicitly warns that doxepin and other antidepressants can precipitate or worsen suicidal ideation, especially when treatment is initiated or doses are adjusted. The black box warning states that patients taking antidepressants for depression may experience:
- Worsening of depression
- Emergence of suicidal ideation and behavior
- Anxiety, agitation, panic attacks
- Hostility, aggressiveness, impulsivity
- Akathisia (psychomotor restlessness)
These symptoms may represent precursors to emerging suicidality, and the FDA recommends considering discontinuation of the medication if depression persistently worsens or emergent suicidality develops 1.
Evidence-Based Alternatives for Suicidal Ideation
Current guidelines provide clear direction on what DOES work for patients with suicidal thoughts:
For patients with recent suicidal ideation or history of self-harm:
- Cognitive behavioral therapy-based psychotherapy focused on suicide prevention (weak recommendation, but the strongest available evidence) 2
- Ketamine infusion as adjunctive treatment for short-term reduction in suicidal ideation in patients with major depressive disorder (weak recommendation) 2
- Clozapine specifically for patients with schizophrenia/schizoaffective disorder who have suicidal ideation (weak recommendation) 2
Clinical Assessment Requirements
Before considering ANY antidepressant in a patient with suicidal thoughts, the 2015 APA guidelines mandate assessment of:
- Current suicidal ideas, plans, and attempts (both active and passive thoughts)
- Patient's intended course of action if symptoms worsen
- Access to lethal means, especially firearms
- Motivations for suicide
- Reasons for living
- Quality of therapeutic alliance
The Bottom Line
Doxepin is contraindicated as a treatment for passive suicidal thoughts. The drug's own labeling warns it may worsen this exact symptom. If underlying depression requires treatment, doxepin should only be prescribed with extreme caution, intensive monitoring for worsening suicidality, and in conjunction with evidence-based psychotherapy. The smallest quantity should be prescribed to reduce overdose risk 1.
Patients and families must be explicitly warned to monitor daily for emergence or worsening of suicidal ideation, particularly in the first weeks of treatment or after dose changes 1.